To clarify, Emvision are taking the 510k pathway rather than De Novo . Previous company presentations had the FDA 510ķ clearance for Gen 1 in FY25. My understanding is it's simpler, faster and cheaper.
To clarify, Emvision are taking the 510k pathway rather than De...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.99 |
Change
-0.010(0.50%) |
Mkt cap ! $169.5M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.06 | $1.99 | $120.4K | 60.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 255 | $1.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.00 | 1000 | 1 |
View Market Depth
| Last trade - 15.55pm 23/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |